Mette Kirstine Agger serves as Executive at scPharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, Mette Kirstine Agger has executed 7 insider transactions totaling $15.9M, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 16, 2020 involved purchasing 187,500 shares valued at $3.0M.
Mette Kirstine Agger currently holds 1,432,722 shares of scPharmaceuticals Inc. (SCPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mette Kirstine Agger has been a net buyer of SCPH stock. They have purchased $15.9M and sold $0 worth of shares.
Mette Kirstine Agger's most recent insider trade was on Mar 16, 2020, when they purchased 187,500 shares at $16.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 9, 2019 | TRVI | $0 | Conversion | 776,544 | $N/A | Discretionary |
| May 9, 2019 | TRVI | $3.8M | Purchase | 375,000 | $10.00 | Discretionary |
| Nov 21, 2017 | SCPH | $9.2M | Purchase | 654,762 | $14.00 | Discretionary |
| Nov 21, 2017 | SCPH | $0 | Conversion | 1,544,858 | $N/A | Discretionary |
| Nov 21, 2017 | SCPH | $0 | Conversion | 984,366 | $N/A | Discretionary |